Search results
Showing 526 to 540 of 557 results for women's health
Biographies and registered interests for members of the Technology Appraisal Committee C
Recommendations in NICE’s type 2 diabetes guideline update, published today, will enhance the use of SGLT-2 inhibitors in primary care and address these health inequalities.
Biggest shake-up in type 2 diabetes care in a decade announced
Millions of people are set to benefit from earlier access to newer type 2 diabetes treatments – the biggest shake-up in care for a decade – as part of NICE’s commitment to re-evaluate priority clinical pathways described in the 10-Year Health Plan for the NHS.
the NHS and beyond. As a NICE committee member, your insights help equip health and care practitioners with the guidance they need to...
Ensuring continuity of care for women from Black, Asian and minority ethnic communities and from the most deprived groups.
Four AI technologies conditionally recommended to help detect undiagnosed fragility fractures
The technologies could help healthcare professionals spot hidden spinal fractures in patients undergoing routine CT scans.
Positive experiences early in life are closely associated with better performance at school, better social and emotional development, improved work outcomes, higher income and better lifelong health, including longer life expectancy.
The report concluded that having enough money to lead a healthy life is central to health and that poverty and low living standards are powerful determinants of ill health and health inequity.
We've mapped relevant NICE guidance and advice to NHS England’s Core20PLUS5 for adults
guidelines to the CQC's single assessment framework NICE and health inequalities Supporting the health and care system to...
We have also recommended osimertinib for routine use on the NHS today.
An insight into one of NICE’s most long-standing collaborative relationships.
New tests could spare people with early breast cancer from unnecessary chemotherapy
More people with early breast cancer could be spared chemotherapy and therefore avoid the side effects associated with the treatment after tumour profiling tests were recommended by NICE.
NICE has outlined what aspects of menopause care will be updated in upcoming guidance, including areas where more research is needed.
NICE calls for further research into the treatment of chronic lipoedema
NICE has today issued interventional procedures guidance on the use of liposuction for the treatment of chronic lipoedema.